VentriPoint Diagnostics (CVE:VPT) Trading 76.5% Higher – Time to Buy?

VentriPoint Diagnostics Ltd. (CVE:VPT) shares traded up 76.5% on Friday . The stock traded as high as C$0.16 and last traded at C$0.15. 3,992,349 shares changed hands during trading, an increase of 1,549% from the average session volume of 242,055 shares. The stock had previously closed at C$0.09.

VentriPoint Diagnostics Trading Down 23.3 %

The stock has a market cap of C$18.65 million, a price-to-earnings ratio of -3.55 and a beta of 0.39. The company has a quick ratio of 6.67, a current ratio of 0.28 and a debt-to-equity ratio of -58.56. The firm’s 50 day moving average is C$0.10 and its two-hundred day moving average is C$0.13.

About VentriPoint Diagnostics

Ventripoint Diagnostics Ltd., a medical device company, engages in the development and commercialization of diagnostic tools that monitor patients with heart disease worldwide. It offers Ventripoint Medical System (VMS), a medical imaging system that is used to generate three-dimensional models with critical volume and functional measurements of a patient’s heart chambers.